Literature DB >> 15385140

Prolonged survival in recurrent endometrial carcinoma to the brain.

Kevin S Elliott1, Mark E Borowsky, Yi-Chun Lee, Chandrakant Rao, Ovadia Abulafia.   

Abstract

BACKGROUND: Recurrence of endometrial cancer in the brain is a rare event generally accompanied by limited life expectancy. We present an unusual case of long-term survival following surgical resection of an intracranial endometrial cancer metastasis. CASE: The present case is a patient with FIGO stage IIB, grade III endometrial cancer which recurred 2 months following completion of primary therapy with an isolated lesion in the brain. Aggressive trimodal therapy was initiated with curative intent and she has remained without clinical or radiographic evidence of disease for more than 30 months following treatment of her recurrence.
CONCLUSIONS: Aggressive multi-modal therapy is warranted in the treatment of isolated intracranial recurrences of endometrial cancer in carefully selected patients. With complete surgical resection of disease, the precise nature and role of adjuvant treatment has yet to be clearly defined.

Entities:  

Mesh:

Year:  2004        PMID: 15385140     DOI: 10.1016/j.ygyno.2004.07.030

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Brain metastases from endometrial carcinoma.

Authors:  Ettie Piura; Benjamin Piura
Journal:  ISRN Oncol       Date:  2012-03-18

2.  Stereotactic radiosurgery for brain metastasis from gynecological malignancies.

Authors:  Ekkehard Kasper; Franziska Ippen; Eric Wong; Eric Uhlmann; Scott Floyd; Anand Mahadevan
Journal:  Oncol Lett       Date:  2017-01-18       Impact factor: 2.967

3.  Brain metastases in patients with low-grade endometrial carcinoma.

Authors:  Paulina Cybulska; Marina Stasenko; Raanan Alter; Vicky Makker; Karen A Cadoo; Yukio Sonoda; Nadeem R Abu-Rustum; Jennifer J Mueller; Mario M Leitao
Journal:  Gynecol Oncol Rep       Date:  2018-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.